ArticleAnnals of clinical and translational neurology2025
Comparative Effect of Standard Versus Extended Interval Dosing of Rituximab or Ocrelizumab in Multiple Sclerosis.
Nabil K El Ayoubi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.